ZJYL (Jin Medical International) Moat Score: 2/10 (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ZJYL Jin Medical International Ltd ZJYL
64 GF Score
Price $1.96
GF Value $14.58
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Jin Medical International Moat Score?

Jin Medical International ZJYL +0.01% 64 Moat Score is 2 as of Jul. 15, 2026. GuruFocus rates ZJYL with a GF Score™ of 64/100 and a GF Value™ of $14.58 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 842 Medical Devices & Instruments companies, Jin Medical International ranks better than 68.29% on this metric.

Jin Medical International has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

Jin Medical International has No Moat: Jin Medical International Ltd lacks significant market leadership or unique intellectual property. The company does not exhibit strong brand strength or customer loyalty, and there are no evident durable cost advantages or regulatory barriers. Its competitive position is weak, with no clear network effects or switching costs.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Jin Medical International might have No Moat - Very weak/transient advantages.

Jin Medical International  (NAS:ZJYL) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Jin Medical International Moat Score Related Terms

ZJYL vs RVP, CUPR, BNGO: Moat Score Comparison

For the Medical Instruments & Supplies subindustry, Jin Medical International's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jin Medical International Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Jin Medical International's Moat Score distribution charts can be found below:

* The bar in red indicates where Jin Medical International's Moat Score falls into.


ZJYL
64GF Score
Jin Medical International Ltd ZJYL
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
Jin Medical International (ZJYL) has a Moat Score of 2 as of Jul. 15, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Jin Medical International ranks #267 out of 842 companies in the Medical Devices & Instruments industry, placing it in the top 31.7%.
Is Jin Medical International's Moat Score too high?
Jin Medical International's current Moat Score is 2. Based on the distribution chart, Jin Medical International ranks #267 out of 842 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Jin Medical International has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jin Medical International's Moat Score compare to RVP and CUPR?
According to the Medical Devices & Instruments industry distribution chart, Jin Medical International ranks #267 out of 842 companies for Moat Score. This puts Jin Medical International in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Jin Medical International's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jin Medical International stock overvalued right now?
Based on GuruFocus' analysis, Jin Medical International (ZJYL) is currently considered Significantly Undervalued. The stock's GF Value™ is $14.58, compared to a current price of $1.96 — trading 86.6% below its estimated fair value. The current Moat Score is 2. Jin Medical International's overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Jin Medical International (ZJYL), the current Moat Score is 2 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jin Medical International (ZJYL) Overvalued in 2026?

Based on GuruFocus' analysis, Jin Medical International stock appears to be undervalued. The current stock price of $1.96 is trading 86.6% below its estimated GF Value™ of $14.58. GuruFocus considers Jin Medical International to be Significantly Undervalued.

Key valuation signals for ZJYL:

  • Moat Score: 2
  • GF Value™: $14.58 vs. price of $1.96 (86.6% below fair value)
  • GF Score™: 64/100 with 7 warning signs

No single metric tells the full story. See the ZJYL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jin Medical International Business Description

Address No. 33 Lingxiang Road, Wujin District, Jiangsu Province, Changzhou, CHN
Jin Medical International Ltd, along with its subsidiaries, mainly offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other assistive living aid products for use by people with disabilities or impaired mobility. The group's product offering includes wheelchairs and wheelchair components, oxygen concentrators, bathing machines, respiratory and walking aids, oxygen chambers, beauty instruments, and nano products, among others. Wheelchairs are currently its key revenue-generating product. The products are sold to dealers in Japan and China, and to some extent to dealers located in the United States, Canada, Australia, Korea, Israel, Singapore, and other regions. Geographically, the group generates maximum revenue from Japan.
64GF Score

Get the complete analysis for ZJYL

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.96
Price
$14.58
GF Value